Member AUM
$70 trillion

Antibiotic Resistance: What Role Do Investors Have In Addressing This Systemic Societal Risk?

shutterstock 1936601782
Key Topic(s)

Part of RI Europe, this event will address the following questions:

  • The economic and social damage from Covid-19 pales in comparison to the potential harm from mass antimicrobial resistance (AMR). Are investors sleeping on this issue?

  • What tools and methodologies can investors use to gauge the risks from AMR?

  • What should be the practical role of investors in addressing AMR?

  • What are the challenges of engaging with companies on systemic, as opposed to idiosyncratic, risk?

Speakers include:

  • Emma Berntman, Senior Engagement Specialist, FAIRR Initiative

  • Sara E. Murphy, Chief Strategy Officer, The Shareholder Commons

  • Suzi van Es, Investor Engagement Manager, Access to Medicine Foundation

The session will be moderated by Georgia Stewart, CEO, tumelo.

Key Information
Date: 14 June 2023
Time: 11:15 - 12:00 BST (UTC+1)
Location: London, UK
Address: 133 Houndsditch, London